<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36974">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02104921</url>
  </required_header>
  <id_info>
    <org_study_id>2K24NS060951</org_study_id>
    <nct_id>NCT02104921</nct_id>
  </id_info>
  <brief_title>Innovative Ultrasound Technology in Neuromuscular Disease</brief_title>
  <acronym>AQUIRe</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is utilizing ultrasound measurement to measure neuromuscular disease status in
      adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that
      ultrasound can be utilized as a tool to determine if a disease is responding to therapy or
      progressing.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Quantitative ultrasound data, including quantified grayscale data and backscattered acoustic data</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Ultrasound data will be collected on multiple muscles in each person. The images will then be quantified using either 1. A grayscale technique in which the images themselves are analyzed via standard image software (e.g., Adobe Photoshop) as to level of echo intensity in a pre-specific region of interest or 2. the raw quantified backscatter data is captured by the transducer, expressed as a unit of power, in the same pre-specified area of interest</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <condition>Muscular Dystrophy</condition>
  <condition>Radiculopathy</condition>
  <condition>Myopathy</condition>
  <condition>Polyneuropathy and Mononeuropathies</condition>
  <arm_group>
    <arm_group_label>Neuromuscular Disease Patients</arm_group_label>
    <description>Amyotrophic lateral sclerosis patients, myopathy patients, muscular dystrophy patients, myasthenia gravis patients, radiculopathy patients, mononeuropathy patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with any neuromuscular disorder (i.e. primary nerve or muscle disease), both
        localized and generalized, producing some degree of weakness or disability.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of a well-defined, localized or generalized neuromuscular condition producing
             weakness or muscle atrophy, including disuse atrophy.

        Exclusion Criteria:

          -  Multiple generalized neuromuscular conditions.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sung Lim</last_name>
    <phone>617-667-3053</phone>
    <email>syim@bidmc.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alex Mijailovic</last_name>
    <phone>617-667-3053</phone>
    <email>amijailo@bidmc.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sung Yim</last_name>
      <phone>617-667-3015</phone>
      <email>syim@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Seward B Rutkove, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Courtney McIlduff, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 2, 2014</lastchanged_date>
  <firstreceived_date>March 31, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beth Israel Deaconess Medical Center</investigator_affiliation>
    <investigator_full_name>Seward Rutkove</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Muscular Diseases</mesh_term>
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Neuromuscular Diseases</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Polyneuropathies</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Mononeuropathies</mesh_term>
    <mesh_term>Radiculopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
